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Background
Human immunodeficiency virus (HIV) patients are at
higher risk for lung cancer than the general population
[1]. The impact of HIV on the lung cancer population is
unclear. In this study, we estimate the prevalence of
HIV among Medicare beneficiaries diagnosed with lung
cancer.
Material and methods
This study used the SEER-Medicare database which links
Medicare claims data with patients identified through
cancer registries as part of the Surveillance Epidemiology
and End Results (SEER) program. There were 250,500
patients who were diagnosed with malignant lung cancer
between 1998 and 2007: 225,233 qualified for Medicare
based on age and were 65 years or older at diagnosis and
25,267 qualified for Medicare based on disability and
were less than 65 years old at diagnosis. Demographic
information was taken at the time of the initial lung
cancer diagnosis. Patients were classified as prevalent
HIV cases if their first Medicare claim with a diagnosis of
HIV preceded the diagnosis of lung cancer or occurred
within one year after lung cancer was diagnosed. Relative
risk (RR) was used to assess risk factors.
Results
The prevalence of HIV in lung cancer cases was 180.6
(95% CI: 163.8 to 199.0) and 1,646.0 (95% CI: 1,495.1 to
1,812.3) per 100,000 among elderly and disabled benefi-
ciaries, respectively. It doubled from 1998 to 2007 for
elderly beneficiaries and increased by 35% for disabled
beneficiaries. Risk factors for HIV were male gender,
non-white race, never having been married, and resi-
dence in a metropolitan area (Table 1).
Elderly HIV and non-HIV patients were comparable
with respect to stage of lung cancer at diagnosis, but
HIV-infected disabled beneficiaries were more likely to
present with distant metastases than their non-HIV
counterparts.
Conclusions
The prevalence of HIV among elderly Medicare benefi-
ciaries with lung cancer was 2.6 higher than in the gen-
eral population 65 years and older[2]. For disabled
beneficiaries, the prevalence of HIV among lung cancer
cases was higher than for those without lung cancer [3].
The increasing prevalence of HIV in lung cancer cases
may result in a commensurate increase in demand for
health care services for Medicare beneficiaries.
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Table 1
Elderly
Beneficiaries RR
Disabled
Beneficiaries RR
Male vs. Female 1.9* 3.5*
African-American vs. White 6.4* 3.1*
Other race vs. White 2.0* 0.7
Never married vs. Other
(Men)
4.8* 7.3*
Never married vs. Other
(Women)
2.2* 4.6*
Big Metro vs Other 5.5* 5.2*
Metro vs. Other 2.9* 2.9*
*RR significantly > 1.0
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